Juvenile mycosis fungoides treated with bexarotene and PUVA

International Journal of Dermatology

Volumn 46, Issue 1, 2007, Pages 99-102

  Rodríguez Vázquez, María ^a   García Arpa, Mónica ^a   González García, Jesús ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BETA 2 MICROGLOBULIN; BEXAROTENE; IMMUNOGLOBULIN E; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE ACEPONATE; RETINOID; THYROXINE;

ADOLESCENT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; CANCER STAGING; CASE REPORT; CAUCASIAN; DERMIS; DRUG WITHDRAWAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFORMED CONSENT; LEUKOCYTE; LOW DRUG DOSE; LYMPHOCYTIC INFILTRATION; MALE; MYCOSIS FUNGOIDES; PHYSICAL EXAMINATION; PRURITUS; PUVA; SKIN BIOPSY; SKIN MANIFESTATION; SKIN NODULE; UNSPECIFIED SIDE EFFECT;

EID: 33845956488     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03147.x     Document Type: Article

References (18)

1. Wain EM, Orchard GE, Whittaker SJ, et al. Outcome in 34 patients with juvenile-onset mycosis fungoides: A clinical, immunophenotypic, and molecular study. Cancer 2003; 98: 2282-2290.
2. Zackheim HS, McCalmont TH, Deanovic FW, et al. Mycosis fungoides with onset before 20 years of age. Review of 24 patients and report of a case diagnosed at age 22 months. J Am Acad Dermatol 1997; 36: 557-562.
3. Garzon MC. Cutaneous T cell lymphoma in children. Semin Cutan Med Surg 1999; 18: 226-232.
4. Fink-Puches R, Chott A, Ardigó M, et al. The spectrum of cutaneous lymphomas in patients less than 20 years of age. Pediatr Dermatol 2004; 21: 525-533.
5. Tan E, Tay YK, Giam YC. Profile and outcome of childhood mycosis fungoides in Singapore. Pediatr Dermatol 2000; 17: 352-356.
6. Roupe G. Hypopigmented mycosis fungoides in a child successfully treated with UVA1-light. Pediatr Dermatol 2005; 22: 82.
7. Taniguchi S, Horio T, Komura J. Mycosis fungoides in the tumor stage treated by PUVA: A successful trial in a 12-year-old girl. Dermatologica 1980; 160: 409-413.
8. Camacho FM, Burg G, Moreno JC, et al. Granulomatous slack skin in childhood. Pediatr Dermatol 1997; 14: 204-208.
9. Meister L, Duarte AM, Davis J, et al. Sezary syndrome in an 11-year-old girl. J Am Acad Dermatol 1995; 122: 686-687.
10. Quaglino P, Zaccagna A, Verrone A, et al. Mycosis fungoides in patients under 20 years of age: Report of 7 cases, review of the literature and study of the clinical course. Dermatology 1999; 199: 8-14.
11. Hickham PR, McBurney EI, Fitzgerald RL. CTCL in patients under 20 years of age: A series of five cases. Pediatr Dermatol 1997; 14: 93-97.
12. Tay YK, Weston WL, Aeling JL. Treatment of childhood cutaneous T-cell lymphoma with alpha-interferon plus PUVA. Pediatr Dermatol 1996; 13: 496-500.
13. Budgin JB, Richardson SK, Newton SB, et al. Biological effects of bexarotene in cutaneous T-cell lymphoma. Arch Dermatol 2005; 141: 315-321.
14. Singh F, Lebwohl MG. Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: A case series. J Am Acad Dermatol 2004; 51: 570-573.
15. McGinnis KS, Junkins-Hopkins JM, Crawford G, et al. Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: Clinical synergism and possible immunologic mechanisms. J Am Acad Dermatol 2004; 50: 375-379.
16. McGinnis KS, Shapiro M, Vittorio CC, et al. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma. Arch Dermatol 2003; 139: 771-775.
17. Ruizmaldonado R, Tamayo-Sánchez L, Orozco-Covarrubias M. The use of retinoids in the pediatric patient. Dermatol Clin 1998; 16: 553-569.
18. Lacour M, Mehta-Nikhar B, Atherton DJ, et al. An appraisal of acitetrin therapy in children with inherited disorders of keratinization. Br J Dermatol 1996; 134: 1023-1029.